Results 221 to 230 of about 779,870 (354)

B-Lymphocyte [PDF]

, 2020
openaire   +1 more source

The effect of leflunomide on B-cell lymphocytes in vitiligo

M.Sc. MOHAMED H. SHEHATA NAHLA H. AHMED, Maha H. Ragaie, Manal Gabril, Sherif Awad   +3 more
openalex   +1 more source

Correction of the molecular defect in B lymphocytes from X-linked agammaglobulinemia by cell fusion. [PDF]

, 1988
Jerrold Schwaber, N Koenig, J. Girard
openalex   +1 more source

Understanding and Overcoming Antibody‐Drug Conjugate Resistance: Biological Mechanisms and Emerging Analytical Frameworks in Breast Cancer

Advanced Science, EarlyView.
Antibody–drug conjugates (ADCs) transform breast cancer therapy, yet resistance limits their durability. Emerging evidence reveals that ADC failure is not solely tumor‐intrinsic but shaped by dynamic tumor–microenvironment interactions that alter drug delivery, processing, and response.
Minji Seo, Jangsoon Lee, Naoto T. Ueno
wiley   +1 more source

Serum-free differentiation platform for the generation of B lymphocytes and natural killer cells from human CD34+ cord blood progenitors. [PDF]

Sci Rep
Bhave R, Kath CJ, Rüchel N, Vasileiou E, Jepsen VH, Raba K, Pandyra AA, Fischer U, Kogler G.   +8 more
europepmc   +1 more source

Proliferation, differentiation, and cytogenetics of chronic leukemic B lymphocytes cultured with mitomycin-treated normal cells [PDF]

, 1981
P Nowell, TV Shankey, J Finan, D Guerry, E Besa   +4 more
openalex   +1 more source

A Nanoparticle‐Integrated Complete Manufacturing Pipeline of Chemically Engineered Exosomes

Advanced Science, EarlyView.
We report a novel manufacture technology of chemically engineered exosomes. The four steps of manufacturing, i.e., biogenesis, loading, isolation, and storage, are integrated by the use of a nanoparticle. The manufacture technology incorporates three innovative components, i.e., a new nano‐bio effect, a new composite nanoparticle, and a new isolation ...
Xiaowei Wen, Zixing Xu, Zerun Hao, Yanming Chen, Kai Xie, Haofan Yin, Xueying Wang, Jie Min, Sihan Sun, Baiding Chen, Chengxiu Ling, Mingming Xu, Yizhao Chen, Gang Ruan   +13 more
wiley   +1 more source

RETRACTED: Upfold et al. Tyrosine Kinase Inhibitors Target B Lymphocytes. <i>Biomolecules</i> 2023, <i>13</i>, 438. [PDF]

Biomolecules
Upfold NLE, Petakh P, Kamyshnyi A, Oksenych V.   +3 more
europepmc   +1 more source

Wnt Signaling Regulates B Lymphocyte Proliferation through a LEF-1 Dependent Mechanism [PDF]

, 2000
Tannishtha Reya, Mary O’Riordan, Ross M. Okamura, Erik Devaney, Karl Willert, Roel Nusse, Rudolf Grosschedl   +6 more
openalex   +1 more source

Targeting Peptostreptococcus anaerobius with an Iron‐Based Nanozyme Reverses Ferroptosis Resistance and Enhances Antitumor Immunity in Colorectal Cancer

Advanced Science, EarlyView.
An iron‐based nanozyme selectively eliminates intratumoral P. anaerobius while catalytically generating ROS to induce ferroptosis, synergistically suppressing colorectal cancer growth and activating anti‐tumor immunity through immunogenic cell death. ABSTRACT The intratumoral microbiota is a critical determinant of therapeutic outcomes in colorectal ...
Yinghao Cao, Jun Wang, Hanwenchen Wang, Xiang Sun, Fang Fang, Shiying Li, Jianping Liu, Changrong Shi, Pengyuan Qi, Jianhua Zou, Xiaoyuan Chen, Kailin Cai   +11 more
wiley   +1 more source